Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Dataset
|
![]() |
QSAR model to predict Kp,uu,brain with a small dataset, incorporating predicted values of related parameterUmemori, Y. ; Handa, K. ; Sakamoto, S. ; Kageyama, M. ; Iijima, T.Taylor & Francis 2022Texto completo disponível |
2 |
Material Type: Dataset
|
![]() |
Supplementary Material for: Impact of functional status on development of Clostridioides difficile infection and increase in in-hospital mortality among antibiotic usersK., Watanabe ; T., Tsuji ; Y., Saruta ; H., Matsuzawa ; Y., Shimodaira ; K., IijimaKarger Publishers 2023Texto completo disponível |
3 |
Material Type: Dataset
|
![]() |
Supplementary Material for: Clinical and Histopathological Features of the Differentiated Type of Early Gastric Cancer with an Unclear Lateral DemarcationK., Nagai ; Y., Hayashi ; R., Uema ; T., Inoue ; K., Kimura ; A., Sakatani ; S., Yoshii ; Y., Tsujii ; S., Shinzaki ; H., Iijima ; T., TakeharaKarger Publishers 2022Texto completo disponível |
4 |
Material Type: Dataset
|
![]() |
Supplementary Material for: Centrilobular Emphysema Is Associated with Pectoralis Muscle Reduction in Current Smokers without Airflow LimitationT., Maetani ; N., Tanabe ; Y., Shiraishi ; T., Shimada ; S., Terada ; H., Shima ; F., Mochizuki ; R., Sakamoto ; S., Kaji ; T., Oguma ; S., Sato ; H., Iijima ; I., Masuda ; T., HiraiKarger Publishers 2023Texto completo disponível |
5 |
Material Type: Dataset
|
![]() |
Supplementary Material for: Objective response by mRECIST to initial lenvatinib therapy is an independent factor contributing to deep response in hepatocellular carcinoma treated with lenvatinib-transcatheter arterial chemoembolization sequential therapyH., Kuroda ; T., Oikawa ; M., Ninomiya ; M., Fujita ; K., Abe ; K., Okumoto ; T., Katsumi ; W., Sato ; G., Igarashi ; C., Iino ; T., Endo ; N., Tanabe ; H., Numao ; S., Fukuda ; K., Iijima ; A., Masamune ; H., Ohira ; Y., Ueno ; Y., TakikawaKarger Publishers 2022Texto completo disponível |
6 |
Material Type: Dataset
|
![]() |
Supplementary Material for: Lenvatinib as second-line treatment after atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma –clinical results show importance of hepatic reserve functionA., Hiraoka ; T., Kumada ; T., Tada ; M., Hirooka ; K., Kariyama ; J., Tani ; M., Atsukawa ; K., Takaguchi ; E., Itobayashi ; S., Fukunishi ; K., Tsuji ; T., Ishikawa ; K., Tajiri ; H., Ochi ; S., Yasuda ; H., Toyoda ; C., Ogawa ; T., Nishimura ; T., Hatanaka ; S., Kakizaki ; N., Shimada ; K., Kawata ; A., Naganuma ; H., Kosaka ; T., Matono ; H., Kuroda ; Y., Yata ; H., Ohama ; F., Tada ; K., Nouso ; A., Morishita ; A., Tsutsui ; T., Nagano ; N., Itokawa ; T., Okubo ; T., Arai ; K., Yokohama ; M., Imai ; Y., Koizumi ; S., Nakamura ; H., Iijima ; M., Kaibori ; Y., HiasaKarger Publishers 2023Texto completo disponível |
7 |
Material Type: Dataset
|
![]() |
Supplementary Material for: Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter studyF., Rossari ; T., Tada ; G., Suda ; S., Shimose ; M., Kudo ; C., Yoo ; J., Cheon ; F., Finkelmeier ; H.Y., Lim ; J., Presa ; G., Masi ; F., Bergamo ; E., Amadeo ; F., Vitiello ; T., Kumada ; N., Sakamoto ; H., Iwamoto ; T., Aoki ; H.J., Chon ; V., Himmelsbach ; M., Iavarone ; G., Cabibbo ; M., Montes ; F.G., Foschi ; C., Vivaldi ; C., Soldà ; T., Sho ; T., Niizeki ; N., Nishida ; C., Steup ; M., Hirooka ; K., Kariyama ; J., Tani ; M., Atsukawa ; K., Takaguchi ; E., Itobayashi ; S., Fukunishi ; K., Tsuji ; T., Ishikawa ; K., Tajiri ; H., Ochi ; S., Yasuda ; H., Toyoda ; C., Ogawa ; T., Nishimura ; T., Hatanaka ; S., Kakizaki ; N., Shimada ; K., Kawata ; A., Hiraoka ; F., Tada ; H., Ohama ; K., Nouso ; A., Morishita ; A., Tsutsui ; T., Nagano ; N., Itokawa ; T., Okubo ; M., Imai ; H., Kosaka ; A., Naganuma ; Y., Koizumi ; S., Nakamura ; M., Kaibori ; H., Iijima ; Y., Hiasa ; M., Persano ; S., Foti ; S., Camera ; B., Stefanini ; M., Scartozzi ; S., Cascinu ; A., Casadei-Gardini ; M., RiminiKarger Publishers 2024Texto completo disponível |
8 |
Material Type: Dataset
|
![]() |
Supplementary Material for: Relationship of atezolizumab plus bevacizumab treatment with muscle volume loss in unresectable hepatocellular carcinoma patients– multicenter analysisA., Hiraoka ; T., Kumada ; T., Tada ; M., Hirooka ; K., Kariyama ; J., Tani ; M., Atsukawa ; K., Takaguchi ; E., Itobayashi ; S., Fukunishi ; K., Tsuji ; T., Ishikawa ; K., Tajiri ; H., Ochi ; S., Yasuda ; H., Toyoda ; C., Ogawa ; T., Nishimura ; T., Hatanaka ; S., Kakizaki ; N., Shimada ; K., Kawata ; A., Naganuma ; M., Kaibori ; T., Tanaka ; H., Ohama ; K., Nouso ; A., Morishita ; A., Tsutsui ; T., Nagano ; N., Itokawa ; T., Okubo ; T., Arai ; M., Imai ; Y., Koizumi ; S., Nakamura ; K., Joko ; H., Iijima ; H., Kosaka ; Y., Hiasa ; M., Kudo ; Group, On behalf of the Real-life Practice Experts for HCC Study ; Group, HCC 48Karger Publishers 2022Texto completo disponível |
9 |
Material Type: Dataset
|
![]() |
Supplementary Material for: Prediction of Neurodevelopmental Impairment in Congenital Cytomegalovirus Infection by Early Postnatal Magnetic Resonance ImagingNishida, K. ; Fujioka, K. ; Sugioka, Y. ; Abe, S. ; Ashina, M. ; Fukushima, S. ; Ohyama, S. ; Ikuta, T. ; Tanimura, K. ; Yamada, H. ; Iijima, K. ; Morioka, I.Karger Publishers 2020Texto completo disponível |
10 |
Material Type: Dataset
|
![]() |
Supplementary Material for: Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumabM., Rimini ; M., Persano ; T., Tada ; G., Suda ; S., Shimose ; M., Kudo ; J., Cheon ; F., Finkelmeier ; H.Y., Lim ; J., PresaRamos ; G., Masi ; C., Yoo ; S., Lonardi ; B., Stefanini ; T., Kumada ; N., Sakamoto ; H., Iwamoto ; T., Aoki ; H.J., Chon ; V., Himmelsbach ; M., Montes ; C., Vivaldi ; C., Soldà ; A., Hiraoka ; T., Sho ; T., Niizeki ; N., Nishida ; C., Steup ; M., Hirooka ; K., Kariyama ; J., Tani ; M., Atsukawa ; K., Takaguchi ; E., Itobayashi ; S., Fukunishi ; K., Tsuji ; T., Ishikawa ; K., Tajiri ; H., Ochi ; S., Yasuda ; H., Toyoda ; C., Ogawa ; T., Nishimura ; T., Hatanaka ; S., Kakizaki ; N., Shimada ; K., Kawata ; F., Tada ; H., Ohama ; K., Nouso ; A., Morishita ; A., Tsutsui ; T., Nagano ; N., Itokawa ; T., Okubo ; T., Arai ; M., Imai ; H., Kosaka ; A., Naganuma ; Y., Koizumi ; S., Nakamura ; M., Kaibori ; H., Iijima ; Y., Hiasa ; V., Burgio ; A., DellaCorte ; F., Ratti ; F., DeCobelli ; L., Aldrighetti ; M., Scartozzi ; S., Cascinu ; A., Casadei-GardiniKarger Publishers 2023Texto completo disponível |